Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Revenue 2010-2024 | UTHR

United Therapeutics annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • United Therapeutics revenue for the quarter ending September 30, 2024 was $0.749B, a 22.89% increase year-over-year.
  • United Therapeutics revenue for the twelve months ending September 30, 2024 was $2.756B, a 25.04% increase year-over-year.
  • United Therapeutics annual revenue for 2023 was $2.328B, a 20.2% increase from 2022.
  • United Therapeutics annual revenue for 2022 was $1.936B, a 14.88% increase from 2021.
  • United Therapeutics annual revenue for 2021 was $1.686B, a 13.63% increase from 2020.
  
United Therapeutics Annual Revenue
(Millions of US $)
2023 $2,328
2022 $1,936
2021 $1,686
2020 $1,483
2019 $1,449
2018 $1,628
2017 $1,725
2016 $1,599
2015 $1,466
2014 $1,289
2013 $1,117
2012 $916
2011 $743
2010 $593
2009 $359
United Therapeutics Quarterly Revenue
(Millions of US $)
2024-09-30 $749
2024-06-30 $715
2024-03-31 $678
2023-12-31 $615
2023-09-30 $609
2023-06-30 $597
2023-03-31 $507
2022-12-31 $492
2022-09-30 $516
2022-06-30 $467
2022-03-31 $462
2021-12-31 $415
2021-09-30 $445
2021-06-30 $447
2021-03-31 $379
2020-12-31 $385
2020-09-30 $380
2020-06-30 $362
2020-03-31 $356
2019-12-31 $311
2019-09-30 $402
2019-06-30 $374
2019-03-31 $363
2018-12-31 $381
2018-09-30 $413
2018-06-30 $445
2018-03-31 $389
2017-12-31 $465
2017-09-30 $446
2017-06-30 $445
2017-03-31 $371
2016-12-31 $409
2016-09-30 $408
2016-06-30 $413
2016-03-31 $369
2015-12-31 $405
2015-09-30 $386
2015-06-30 $347
2015-03-31 $328
2014-12-31 $346
2014-09-30 $330
2014-06-30 $323
2014-03-31 $289
2013-12-31 $289
2013-09-30 $302
2013-06-30 $281
2013-03-31 $245
2012-12-31 $244
2012-09-30 $242
2012-06-30 $226
2012-03-31 $204
2011-12-31 $195
2011-09-30 $202
2011-06-30 $184
2011-03-31 $163
2010-12-31 $161
2010-09-30 $169
2010-06-30 $135
2010-03-31 $129
2009-12-31 $98
2009-09-30 $97
2009-06-30 $84
2009-03-31 $80
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.153B $2.328B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $80.389B 30.93
Takeda Pharmaceutical (TAK) Japan $42.701B 8.89
Merck (MKKGY) Germany $19.070B 17.08
Astellas Pharma (ALPMY) Japan $18.241B 16.80
Sandoz Group AG (SDZNY) Switzerland $17.921B 0.00
Summit Therapeutics (SMMT) United States $13.149B 0.00
Neurocrine Biosciences (NBIX) United States $12.828B 33.97
Shionogi (SGIOY) Japan $11.961B 11.98
Catalent (CTLT) United States $11.448B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.641B 0.00
Orion OYJ (ORINY) Finland $6.458B 18.16
Corcept Therapeutics (CORT) United States $5.805B 43.97
Ionis Pharmaceuticals (IONS) United States $5.781B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.976B 0.00
PTC Therapeutics (PTCT) United States $3.576B 0.00
Dyne Therapeutics (DYN) United States $2.618B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.550B 11.56
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.426B 14.50
NewAmsterdam Pharma (NAMS) Netherlands $2.281B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.185B 0.00
Soleno Therapeutics (SLNO) United States $2.014B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.992B 0.00
Xencor (XNCR) United States $1.682B 0.00
Indivior (INDV) United States $1.595B 6.50
Evotec AG (EVO) Germany $1.591B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.560B 0.00
Guardian Pharmacy Services (GRDN) United States $1.472B 0.00
Ocular Therapeutix (OCUL) United States $1.366B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.342B 0.00
Harrow (HROW) United States $1.264B 0.00
Ardelyx (ARDX) United States $1.236B 0.00
ARS Pharmaceuticals (SPRY) United States $1.157B 0.00
Enliven Therapeutics (ELVN) United States $1.131B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.001B 0.00
Collegium Pharmaceutical (COLL) United States $0.970B 5.30
Bioventus (BVS) United States $0.895B 28.28
Relay Therapeutics (RLAY) United States $0.788B 0.00
Oruka Therapeutics (ORKA) United States $0.768B 0.00
Cronos Group (CRON) Canada $0.738B 0.00
USANA Health Sciences (USNA) United States $0.698B 12.95
Altimmune (ALT) United States $0.642B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.565B 0.00
Tourmaline Bio (TRML) United States $0.559B 0.00
Savara (SVRA) United States $0.551B 0.00
OmniAb (OABI) United States $0.535B 0.00
Elite Pharmaceuticals (ELTP) United States $0.526B 0.00
ProKidney (PROK) United States $0.524B 0.00
Xeris Biopharma Holdings (XERS) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.486B 0.00
Verve Therapeutics (VERV) United States $0.483B 0.00
Zevra Therapeutics (ZVRA) United States $0.453B 0.00
Organogenesis (ORGO) United States $0.451B 0.00
Esperion Therapeutics (ESPR) United States $0.443B 0.00
Siga Technologies (SIGA) United States $0.441B 5.15
Korro Bio (KRRO) United States $0.439B 0.00
KalVista Pharmaceuticals (KALV) United States $0.429B 0.00
Akebia Therapeutics (AKBA) United States $0.404B 0.00
Larimar Therapeutics (LRMR) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 135.07
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Avita Medical (RCEL) United States $0.320B 0.00
4D Molecular Therapeutics (FDMT) United States $0.300B 0.00
Aldeyra Therapeutics (ALDX) United States $0.292B 0.00
Nature's Sunshine Products (NATR) United States $0.288B 17.15
Amylyx Pharmaceuticals (AMLX) United States $0.282B 0.00
Heron Therapeutics (HRTX) United States $0.243B 0.00
Inhibikase Therapeutics (IKT) United States $0.231B 0.00
Aclaris Therapeutics (ACRS) United States $0.230B 0.00
Lexeo Therapeutics (LXEO) United States $0.227B 0.00
Profound Medical (PROF) Canada $0.222B 0.00
Acrivon Therapeutics (ACRV) United States $0.220B 0.00
Lyell Immunopharma (LYEL) United States $0.197B 0.00
Silence Therapeutics (SLN) United Kingdom $0.193B 0.00
MediWound (MDWD) Israel $0.186B 0.00
Nektar Therapeutics (NKTR) United States $0.186B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.184B 0.00
CytoDyn (CYDY) United States $0.168B 0.00
Nanobiotix S.A (NBTX) France $0.157B 0.00
Inotiv (NOTV) United States $0.155B 0.00
Telomir Pharmaceuticals (TELO) United States $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.141B 0.00
VAXART, INC (VXRT) United States $0.135B 0.00
Galectin Therapeutics (GALT) United States $0.132B 0.00
Cassava Sciences (SAVA) United States $0.132B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.123B 0.00
Metagenomi (MGX) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.109B 0.00
Journey Medical (DERM) United States $0.106B 0.00
Context Therapeutics (CNTX) United States $0.104B 0.00
Century Therapeutics (IPSC) United States $0.104B 0.00
Regulus Therapeutics (RGLS) United States $0.103B 0.00
Fractyl Health (GUTS) United States $0.098B 0.00
Pyxis Oncology (PYXS) United States $0.096B 0.00
Avalo Therapeutics (AVTX) United States $0.096B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Karyopharm Therapeutics (KPTI) United States $0.088B 0.00
Assertio Holdings (ASRT) United States $0.088B 23.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
ESSA Pharma (EPIX) Canada $0.073B 0.00
Swiftmerge Acquisition (IVCP) United States $0.072B 0.00
OptiNose (OPTN) United States $0.071B 0.00
Scienture Holdings (SCNX) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.062B 0.00
AlloVir (ALVR) United States $0.052B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
CASI Pharmaceuticals (CASI) China $0.048B 0.00
BioVie (BIVI) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.046B 0.00
Nutriband (NTRB) United States $0.046B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Gain Therapeutics (GANX) United States $0.043B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Tempest Therapeutics (TPST) United States $0.035B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.035B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 0.00
Incannex Healthcare (IXHL) Australia $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
DURECT (DRRX) United States $0.023B 0.00
Vivos Therapeutics (VVOS) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
PolyPid (PYPD) Israel $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
Heatwurx (PCSA) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
Jupiter Neurosciences (JUNS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.63
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.71